Cargando…

Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells

Induction of Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) has been demonstrated to be involved in cisplatin resistance in ovarian cancer. Solute carrier family 40 member 1 (SLC40A1) is an iron exporter, which possesses many putative Nrf2 binding sites. Here we hypothesize that it may b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianfa, Bao, Lingjie, Zhang, Zhenbo, Yi, Xiaofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706814/ https://www.ncbi.nlm.nih.gov/pubmed/29212168 http://dx.doi.org/10.18632/oncotarget.19548

Ejemplares similares

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
por: BAO, LINGJIE, et al.
Publicado: (2015)

ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression
por: Wu, Geyan, et al.
Publicado: (2021)

Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
por: Zhang, Lei, et al.
Publicado: (2019)

SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway
por: Sun, Xiaodan, et al.
Publicado: (2019)

PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer
por: Akasu‐Nagayoshi, Yoko, et al.
Publicado: (2022)

Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway
por: Kilic, Ulkan, et al.
Publicado: (2013)

Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)

Associated Effect of SLC40A1 and TMPRSS6 Polymorphisms on Iron Overload
por: Duca, Lorena, et al.
Publicado: (2022)

Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression
por: Zhao, Zhao, et al.
Publicado: (2019)

Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
por: Wu, Shouhai, et al.
Publicado: (2016)

Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer
por: Pishas, Kathleen I., et al.
Publicado: (2021)

miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
por: Wang, Yanan, et al.
Publicado: (2018)

The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells
por: Kucukkaya, Bahire, et al.
Publicado: (2021)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer
por: Wang, Huan, et al.
Publicado: (2022)

The Effect of SLC2A3 Expression on Cisplatin Resistance of Colorectal Cancer Cells
por: Li, Yan, et al.
Publicado: (2021)

The nucleoplasmic phase of pre-40S formation prior to nuclear export
por: Cheng, Jingdong, et al.
Publicado: (2022)

Zinc Finger Protein 90 Knockdown Promotes Cisplatin Sensitivity via Nrf2/HO-1 Pathway in Ovarian Cancer Cell
por: Wu, Ching-Hu, et al.
Publicado: (2023)

Norcantharidin induces ferroptosis via the suppression of NRF2/HO-1 signaling in ovarian cancer cells
por: Zhu, Xiaoyan, et al.
Publicado: (2022)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization
por: Huang, Bin, et al.
Publicado: (2022)

PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
por: Kitamura, Sachiko, et al.
Publicado: (2021)

Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway
por: Jiang, Shaoyan, et al.
Publicado: (2019)

MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer
por: Quiñones-Díaz, Blanca I., et al.
Publicado: (2020)

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
por: Wang, Yiying, et al.
Publicado: (2016)

CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer
por: Luo, Chenshuo, et al.
Publicado: (2020)

The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours
por: Hannon Barroeta, Patricia, et al.
Publicado: (2023)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling
por: Xu, Teng, et al.
Publicado: (2023)

CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
por: Zhang, Xiaoqian, et al.
Publicado: (2023)

Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection
por: Willemetz, Alexandra, et al.
Publicado: (2017)

Role of Mex67-Mtr2 in the Nuclear Export of 40S Pre-Ribosomes
por: Faza, Marius B., et al.
Publicado: (2012)

Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
por: Zuo, Yufang, et al.
Publicado: (2018)

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
por: Takahashi, Ryosuke, et al.
Publicado: (2023)

Estradiol protects hair cells from cisplatin-induced ototoxicity via Nrf2 activation
por: Adachi, Masahiro, et al.
Publicado: (2023)

How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps
por: Blair, Jessica M. A., et al.
Publicado: (2016)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

3′,4′,5′,5,7-Pentamethoxyflavone Sensitizes Cisplatin-Resistant A549 Cells to Cisplatin by Inhibition of Nrf2 Pathway
por: Hou, Xiangyu, et al.
Publicado: (2015)

The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer
por: Deng, Xinyue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dl4iohlu7e29vuggpa722kkrq6